AMISULPRIDE 50 WINTHROP amisulpride 50 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amisulpride 50 winthrop amisulpride 50 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride -

AMISULPRIDE WINTHROP amisulpride 100mg/mL oral solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

amisulpride winthrop amisulpride 100mg/ml oral solution bottle

sanofi-aventis australia pty ltd - amisulpride -

SOLIAN 400 amisulpride 400 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

solian 400 amisulpride 400 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride, quantity: 400 mg - tablet, film coated - excipient ingredients: titanium dioxide; peg-40 stearate; magnesium stearate; lactose monohydrate; hypromellose; microcrystalline cellulose; sodium starch glycollate type a - the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorder) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominantly negative symptoms.

SULPRIX amisulpride 200 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sulprix amisulpride 200 mg tablets blister pack

alphapharm pty ltd - amisulpride, quantity: 200 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; hypromellose; lactose monohydrate; sodium starch glycollate type a - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SULPRIX amisulpride 100 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sulprix amisulpride 100 mg tablets blister pack

alphapharm pty ltd - amisulpride, quantity: 100 mg - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; hypromellose; sodium starch glycollate type a - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SOLIAN 400 MG Israel - English - Ministry of Health

solian 400 mg

sanofi israel ltd - amisulpride - film coated tablets - amisulpride 400 mg - amisulpride - amisulpride - treatment of schizophrenia.

SOLIAN TABLET 400 mg Singapore - English - HSA (Health Sciences Authority)

solian tablet 400 mg

sanofi-aventis singapore pte. ltd. - amisulpride - tablet, film coated - 400 mg - amisulpride 400 mg

SOLIAN 200 amisulpride 200 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

solian 200 amisulpride 200 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride, quantity: 200 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; hypromellose; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SOLIAN 100 amisulpride 100 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

solian 100 amisulpride 100 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride, quantity: 100 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; lactose monohydrate; hypromellose; magnesium stearate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SOLIAN amisulpride 100mg/mL oral solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

solian amisulpride 100mg/ml oral solution bottle

sanofi-aventis australia pty ltd - amisulpride, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: methyl hydroxybenzoate; hydrochloric acid; propyl hydroxybenzoate; purified water; potassium sorbate; saccharin sodium; gluconolactone; sodium gluconate; flavour - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.